In silico identification of membrane associated candidate drug targets in Neisseria gonorrhoeae

International Journal of Integrative Biology

Volumn 6, Issue 2, 2009, Pages 65-67

  Barh, Debmalya ^a   Misra, Amarendra Narayana ^b  

^a Institute of Integrative Omics and Applied Biotechnology IIOAB   (India)

^b FAKIR MOHAN UNIVERSITY   (India)

Author keywords

Essential genes; Genome analysis; Membrane localized drug targets; Neisseria gonorrhoeae

Indexed keywords

ABC TRANSPORTER; COMPETENCE LIPOPROTEIN; DEXTRO ALANINE DEXTRO ALANINE LIGASE; FIMBRIUM PROTEIN; GLYCODEPSIPEPTIDE; GLYCOPEPTIDE; HYPOTHETICAL PROTEIN; LIPOGLYCOPEPTIDE; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; PILIN PROTEIN TYPE 4; PROTEIN NGA 33; THIAMINE BIOSYNTHESIS PROTEIN; TRANSFERRIN BINDING PROTEIN A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; COMPUTER MODEL; CONTROLLED STUDY; GENOMICS; HOST PATHOGEN INTERACTION; HUMAN; NEISSERIA GONORRHOEAE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN TARGETING;

NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 67649549976     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Allsop AE (1998) New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. Curr. Opin. Microbiol. 1: 530-534.
2. Bhasin M, Garg A, et al. (2005) PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics. 21: 2522-2524.
3. Bolan G, Ehrhardt AA, et al. (1999) Gender perspectives and STDs. Sexually transmitted diseases. McGraw-Hill, New York, ISBN: 0071417486, pp: 117-127.
4. Bos MP, Tefsen B, et al. (2005) Function of neisserial outer membrane phospholipase A in autolysis and assessment of its vaccine potential. Infect. Immun. 73: 2222-2231.
5. Chen A, Boulton PongoskiJ IC, et al. (2003) Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. AIDS. 17: 625-628.
6. Chong CE, Lim BS, et al. (2006) In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets. In Silico Biol. 6: 341-346.
7. Densen P (1989) Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin. Microbiol. Rev. 2: S11-S17.
8. Densen P, MacKeen LA, et al. (1982) Dissemination of gonococcal infection is associated with delayed stimulation of complementdependent neutrophil chemotaxis in vitro. Infect. Immun. 38: 563-572.
9. Dutta A, Singh SK, et al. (2006) In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol. 6: 43-47.
10. Gardy JL, Laird MR, et al. (2005) PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics. 21: 617-623.
11. Gerbase AC, Rowley JT, et al. (1998) Global epidemiology of sexually transmitted diseases. Lancet. 351(Suppl. 3): 2-4.
12. Handsfield HH (1990) Neisseria gonorrhoeae. In: Principles and practice of infectious disease. Churchill Livingstone, New York: ISBN-10: 044307593X, pp: 1613-1631.
13. Imai K, Asakawa N, et al. (2008) SOSUI-GramN: high performance prediction for sub-cellular localization of proteins in Gram-negative bacteria. Bioinformation. 2: 417-421.
14. Knapp JS and Rice RJ (1995) Neisseria and Branhamella. In: Manual of clinical microbiology. ASM Press, Washington DC: ISBN: 978-1-55581-371-0, pp: 324-340.
15. Lin JSL, Donegan SP, et al. (1994) Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J. Infect. Dis. 178: 1707-1712.
16. Ogata H, Goto S, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids. Res. 27: 29-34.
17. Perumal D, Lim CS, et al. (2007) Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification. In Silico Biol. 7: 453-465.
18. Price GA, Russell MW, et al. (2005) Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect. Immun. 73: 3945-3953.
19. Sakharkar KR, Sakharkar MK, et al. (2004) A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol. 4: 355-360.
20. Salama NR, Shepherd B, et al. (2004) Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J. Bacteriol. 186: 7926-7935.
21. Schmid MB (1998) Novel approaches to the discovery of antimicrobial agents. Curr. Opin. Chem. Biol. 2: 529-534.
22. Sharma V, Gupta P, et al. (2008) In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila. In Silico Bio. l 8: 331-338.
23. Snyder LA, Butcher SA, et al. (2001) Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp. Microbiology. 147: 2321-2332.
24. Sparling PF (1999) Biology of Neisseria gonorrhoeae. Sexually transmitted diseases. McGraw-Hill, New York: ISBN: 0071417486, pp: 433-449.
25. Sweet RL, Blankfort-Doyle M, et al. (1986) The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA. 255: 2062-2064.
26. Thomas CE, Zhu W, et al. (2006) Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles. Infect. Immun. 74: 1612-1620.
27. Workowski KA and Levine WC (2002) Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly. Rep. 51(RR06): 1-80.
28. Yu CS, Lin CJ, et al. (2004) Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Science. 13: 1402-1406.
29. Zhang R, Ou HY, et al. (2004) DEG: A database of essential genes. Nucleic Acids Res. 32: D271-D272.